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Abstract
Deletion of the glycerol channel aquaporin-9 (Aqp9) reduces postprandial
blood glucose levels in leptin receptor–deficient (db/db) obese mice on a
C57BL/6 9 C57BLKS mixed genetic background. Furthermore, shRNA-medi-
ated reduction of Aqp9 expression reduces liver triacylglycerol (TAG) accumu-
lation in a diet-induced rat model of obesity. The aim of this study was to
investigate metabolic effects of Aqp9 deletion in coisogenic db/db mice of the
C57BL/6 background. Aqp9wt db/db and Aqp9/ db/db mice did not differ in
body weight and liver TAG contents. On the C57BL/6 genetic background, we
observed elevated plasma glucose in Aqp9/ db/db mice (+1.1 mmol/L, life-
time average), while plasma insulin concentration was reduced at the time of
death. Glucose levels changed similarly in pentobarbital anesthetized, glucagon
challenged Aqp9wt db/db and Aqp9/ db/db mice. Liver transcriptional profil-
ing did not detect differential gene expression between genotypes. Metabolite
profiling revealed a sex independent increase in plasma glycerol (+55%) and
glucose (+24%), and reduction in threonate (all at q < 0.1) in Aqp9/ db/db
mice compared to controls. Metabolite profiling thus confirms a role of AQP9
in glycerol metabolism of obese C57BL/6 db/db mice. In this animal model of
obesity Aqp9 gene deletion elevates plasma glucose and does not alleviate hep-
atosteatosis.
Introduction
Aquaporin-9 (AQP9), a member of the major intrinsic
protein family of transmembrane channels is permeable
to glycerol, urea, and some other small, neutral solutes
(Tsukaguchi et al. 1998). Expression has been demon-
strated primarily in hepatocytes, along sinusoidal mem-
branes as well as in a few other cell types (Rojek et al.
2008). In mice, Aqp9 gene deletion results in elevated
plasma glycerol levels (Rojek et al. 2007). Experiments in
primary hepatocytes and perfused livers have demon-
strated that AQP9 is essential for efficient glycerol
gluconeogenesis (Jelen et al. 2011). Consistently, AQP9
expression is enhanced by prolonged fasting (Kuriyama
et al. 2002; Calamita et al. 2012), whereby elevation in
protein levels has been found specifically in male mice
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(Lebeck et al. 2012, 2015). Furthermore, Aqp9 gene dele-
tion has resulted in lower 4-h fasting blood glucose values
in a leptin receptor–deficient db/db mouse model of type
2 diabetes (Rojek et al. 2007). The latter experiments were
conducted in mice on a mixed C57BL/6 9 C57BLKS
genetic background (Rojek et al. 2007). These results have
confirmed findings from in vitro and ex vivo experiments,
but do not rule out that reduced blood glucose levels in
Aqp9/ db/db may be the result of genetic linkage
between Aqp9 and a hypothetic modifier gene that differs
between the C57BL/6 and the C57BLKS strains.
Besides its function in glycerol gluconeogenesis, hepato-
cyte glycerol uptake through AQP9 may supplement tria-
cylglycerol (TAG) synthesis (Lebeck et al. 2015). In
agreement with this hypothesis, shRNA-mediated silenc-
ing of Aqp9 has alleviated nonalcoholic fatty liver disease
(NAFLD) in a diet-induced rat model of obesity (Cai
et al. 2013). In this study we have conducted a compre-
hensive phenotypic analysis of coisogenic Aqp9wt and
Aqp9/ mice, aiming for enhanced understanding of the
metabolic role of AQP9 in mice on the C57BL/6 db/db
genetic background, including its proposed role in TAG
synthesis and NAFLD.
Materials and Methods
Animals
Experimental animals were housed in a specified patho-
gen-free facility at the Department of Biology, Lund
University, Sweden. Aqp9/ C57BL/6 mice have been
described previously (Rojek et al. 2007). B6.BLKS(D)-
Leprdb/J mice, a backcross of the Leprdb allele from BLKS
into the C57BL/6 background, performed at Jackson labo-
ratories, were obtained from Charles River Laboratories,
Germany, and bred with Aqp9/ C57BL/6 mice to obtain
double mutants. Genotyping was performed as previously
described in detail (Rojek et al. 2007; The Jackson
Laboratory protocols database). Body weight and 4 h fast-
ing blood glucose (ACCU-CHEK Aviva glucose meter
from punctured tail vein) were determined weekly
between 6 and 18 weeks of age. For the final 2 experi-
mental weeks, mice were fed a specified content control
diet (Altromin, Germany, #20000033). The diet was
thawed 3–5 times per week from aliquots of one diet
batch. All procedures were approved by the Malm€o–Lund
ethical committee for animal experiments.
Sample collection and preparation
At 18 weeks of age mice were starved for 4 h, anes-
thetized (fentanyl/medetomidine/midazolam, 0.05/5/
0.5 mg/kg body weight, intraperitoneal), decapitated, and
exsanguinated into microvette 500 (Sarstedt) lithium–
heparin tubes for plasma preparation. Following laparo-
tomy, approximately 50 mg of liver tissue was excised
quickly, weighed, briefly homogenized in 1 mL of ice-cold
methanol/water (1/1, v/v), and frozen in liquid nitrogen
(liver sample 1). Another liver aliquot was placed into
TRIzol (Invitrogen, Carlsbad, CA), homogenized, and fro-
zen in liquid nitrogen (liver sample 2). Plasma samples
were subsequently frozen in liquid nitrogen.
Hormone and lipid analysis
Liver sample 1 was thawed and the volume adjusted by
methanol/water (1/1, v/v) to yield a tissue concentration
of 50 mg/mL. The sample was then homogenized and
metabolites and lipids were extracted as previously
described in detail (Want et al. 2013). TAGs were ana-
lyzed utilizing a commercial kit (Sigma-Aldrich, Schell-
dorf, Germany, adipogenesis kit) from organic extract
dried under a stream of nitrogen. Plasma insulin levels
were determined by a mouse insulin ELISA (Mercodia,
Sweden).
Microarrays
RNA for microarray analysis was isolated from liver sam-
ple 2 utilizing the TRIzol Plus RNA Purification System
(Invitrogen). Hybridization to Affymetrix Mouse Gene
2.1 ST chips and data collection was performed by KFB
Regensburg, Germany. Microarray data are available in
the ArrayExpress database (http://www.ebi.ac.uk/arrayex-
press) under accession number E-MTAB-3526. Data were
processed using the oligo package in R/Bioconductor v3.1
(Gentleman et al. 2004). CEL files were background cor-
rected using the RMA method and quantile normalized.
Probesets with interquartile percentage (iqrPCT) greater
than 0.1 were selected with genefilter v1.46.1. Probesets
representing controls were excluded prior to further anal-
ysis. Differentially expressed genes were selected based on
Student’s t-test after correction for multiple comparisons
using the Benjamini–Hochberg method (FDR < 0.1).
Metabolite profiling
Fifty microliters of aqueous metabolite extract from liver
sample 1 was vacuum centrifuged and metabolites were
derivatized as previously described in detail (Danielsson
et al. 2010). Plasma metabolites were extracted from
15 lL plasma using a one-phase liquid extraction proto-
col, vacuum centrifuged, and derivatized as previously
described in detail (Spegel et al. 2010; Spegel et al. 2013).
Metabolites were analyzed on an Agilent 6890N gas
chromatograph (Agilent, Atlanta, GA), equipped with a
2015 | Vol. 3 | Iss. 9 | e12538
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30 m DB-5 msec Ultra Inert column (ID 250 lm, phase
thickness 0.25 lm; Agilent), connected to a Leco Pegasus
III TOFMS electron impact time of flight mass spectrom-
eter (Leco Corp., St. Joseph, MI), as previously described
(Danielsson et al. 2010; Spegel et al. 2010; Spegel et al.
2013). Data were acquired using Leco ChromaTof (Leco
Corp.) and processed by hierarchical multivariate curve
resolution in MATLAB 7.0 (Mathworks, Natick, MA) as
previously described (Jonsson et al. 2006). Metabolites
were normalized using a set of stable isotope labeled
internal standards (Chorell et al. 2009) and identified by
retention indexes, calculated from injection of a homolo-
gous alkane series, and mass spectra, using in house
developed libraries.
The normalized data were further analyzed in Simca
v13.0 (Umetrics AB, Umea, Sweden). An orthogonal pro-
jections to latent structures discriminant analysis (OPLS-
DA) model was built using the genotypes as classes. The
model had four significant components, one predictive
and three orthogonal. The proportion of explained varia-
tion in the X-matrix (R2X) and the Y-matrix (R2Y) were
0.581 and 0.88, respectively. The predictive ability based
on sevenfold cross-validation (Q2) was 0.384. Details
about experimental design as well as raw spectral data are
available at the Metabolights database (http://www.ebi.a-
c.uk/metabolights; accession number MTBLS219).
Glucagon challenge
Mice at 18–20 weeks of age were starved for 16 h, from
17:00 h until 9:00 h, before intraperitoneal injection with
pentobarbital (90 mg/kg). Anesthetized mice were used to
reduce stress-induced glucocorticoid influence on gluco-
neogenesis. Pentobarbital was chosen for its minor effects
on glucose metabolism in rodents (Johansen et al. 1994).
Blood glucose was measured from the tail tip before and
15, 30, 60, and 90 min after a single subcutaneous gluca-
gon injection (0.1 mg/kg body weight, in normal saline;
Novo Nordisk). Mice were kept on isothermal pads dur-
ing the procedure.
Statistical analyses were performed as indicated in the
text and in figure legends, utilizing Prism 5 (Graphpad,
La Jolla, CA) and Simca v13.0 (Umetrics).
Results
Two groups of animals were analyzed in the current
study: Aqp9+/+ and Aqp9+/ were collectively considered
wild type with regard to AQP9 protein function (Aqp9wt)
and compared to Aqp9/ mice. No statistically signifi-
cant effects of heterozygosity were observed in this study
(e.g., relative plasma glycerol in metabolite profiling data
described below, Aqp9+/+ – 100%, n = 4, vs. Aqp9+/ –
113%, n = 12, Student’s t-test, P = 0.66). In order to
investigate the role of AQP9 in coisogenic C57BL/6 db/db
mice we crossed the original C57BL/6 Aqp9/ strain
(Rojek et al. 2007) with C57BL/6 db/db mice and moni-
tored body weight and blood glucose of F2 generation
mice, between 6 and 18 weeks of age. Body weight devel-
oped similarly in both groups of animals (Fig. 1A). Fasted
blood glucose levels tended to be higher in Aqp9/ than
in Aqp9wt mice on the C57BL/6 db/db genetic background
(Fig. 1B), which contrasts previous observations in
C57BL/6 9 C57BLKS mice (Rojek et al. 2007). Consistent
with known hyperinsulemia in db/db mice, plasma insulin
was high and variable in both groups of mice, showing
unequal data distribution between genotypes with no nor-
mal data distribution in AQP9/ mice (Fig. 1C). Analy-
sis by t-test was thus conducted on log2-transformed
data, which identified lower plasma insulin in Aqp9/
mice (P = 0.03; Fig. 1C).
Glycerol gluconeogenesis is physiologically most impor-
tant after prolonged starvation (Calamita et al. 2012),
when glycogen carbohydrate reserves have been depleted.
We therefore exposed obese Aqp9wt and Aqp9/ mice to
16 h of starvation, before injection with glucagon to tem-
porarily elevate hepatic glucose output. Blood glucose
changed similarly in both genotypes indicating similar
hepatic glucagon sensitivity (Fig. 1D).
Recent studies have described reduced hepatosteatosis
in a rat model of diet-induced obesity (DIO) when Aqp9
expression was reduced by shRNA (Cai et al. 2013). Thus,
we tested the effect of Aqp9 deletion on triglyceride levels
in liver tissue of C57BL/6 db/db mice (Fig. 1E). Liver
TAG content did not differ between Aqp9wt and Aqp9/
mice (Fig. 1E).
In order to comprehensively characterize phenotypic
effects of Aqp9 deletion in C57BL/6 db/db mice we con-
ducted microarray gene expression profiling of liver tissue
as well as GC-MS metabolic profiling of liver tissue and
blood plasma preparations. Univariate analysis of microar-
ray gene expression revealed differential expression of only
two genes between Aqp9wt and Aqp9/ mice (FDR < 0.1):
expression of Aqp9 as well as cytochrome b5 reductase 4 (Cy-
b5r4) were lower in Aqp9/ mice (23% and 72% of
Aqp9wt, respectively). Microarray signal intensity for Cy-
b5r4 was, however, low in liver tissue preparations of both
genotypes, and Cyb5r4 function was thus not further inves-
tigated.
Finally, we investigated alterations in circulating and
liver metabolites by GC/MS. To this end, we determined
relative levels of 61 and 84 metabolites in plasma and
liver samples, respectively. Plasma concentrations of glu-
cose, glycerol, and threonate differed between genotypes
(FDR < 0.1; Data S1). Furthermore, OPLS-DA allowed
classification of Aqp9wt and Aqp9/ samples (Fig. 2A).
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Changes in metabolite levels underlying the observed clus-
tering were investigated in the corresponding VIP plot.
Thereby, in addition to the three metabolites identified by
univariate analysis, two TCA cycle intermediates, fuma-
rate and malate, were ranked highest by OPLS-DA VIP
score (both VIP score 1.8; Fig. 2B).
Further inspection of these five metabolites revealed
that average plasma glycerol and glucose concentrations
were higher, and threonic acid, fumarate, and malate were
lower in Aqp9/ mice of both genders. In contrast nei-
ther univariate analysis (FDR < 0.1) nor OPLS-DA iden-
tified differences between metabolite profiles of Aqp9wt
and Aqp9/ liver preparations. We note, however, that
in agreement with plasma glucose values, average glucose-
6-phosphate (1.6-fold), fructose-1-phosphate and 6-phos-
phate (1.5-fold), and glucose (1.2-fold) were elevated in
liver samples of Aqp9/ (nominal P < 0.05; Data S2).
In order to improve detection of moderate yet biologi-
cally meaningful differences between genotypes in gene
expression and metabolite profiling we constructed gene–
compound metabolic networks, utilizing Metscape (GAO
et al. 2010; Karnovsky et al. 2012) in Cytoscape (Cline
et al. 2007). Plasma metabolites of VIP score >1 (Fig. 2B)
were used as input and suggested three metabolic net-
works, an amino acid metabolism–TCA cycle–butanoate
metabolism network, a nucleotide metabolism network,
and a glycerol metabolism network. Lists of genes in these
networks were compared to top-ranked, albeit at
FDR > 0.1, differentially expressed genes in Aqp9wt and
Aqp9/ liver microarrays. This approach identified 50-nu-
cleotidase, ecto (Nt5e) as part of the nucleotide network
involving the metabolites adenine and uracil. The expres-
sion of this transcript appeared elevated in both male and
female KO mice (Fig. 2C). Upon further inspection, we
A
D E
B C
Figure 1. Phenotypic analysis of Aqp9wt and Aqp9/ C57BL/6 db/db mice. (A) Body weight increased similarly in Aqp9wt and Aqp9/ mice
(mean, SEM). (B) Cumulative analysis of life-time blood glucose levels revealed elevated blood glucose in Aqp9/ mice (P = 0.02; whiskers
indicate min–max). (C) Plasma insulin data as shown were not normally distributed for AQP9/ mice (D’Agostino & Pearson omnibus normality
test, P < 0.0001). Accordingly, log2-transformed data analysis showed reduced plasma insulin in AQP9
/ mice (P = 0.03, mean, SEM). (D)
Glucagon challenge induced similar elevation in blood glucose in both genotypes (mean, SEM). (E) Liver TAG content did not differ between
genotypes. Aqp9wt (WT), solid discs; Aqp9/ (KO), open squares. Differences between groups were assessed by two-way ANOVA (A, D) or
Student’s t-test (B, C, E), for n = 25 (KO) and n = 46 (WT) in (A, B), n = 12 (KO) and n = 16 (WT) in (C), n = 11 (KO) and n = 12 (WT) in (D),
and n = 13 (KO) and n = 17 (WT) in (E).
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noticed that expression of the transcript Bckdhb, encoding
the catalytic subunit of branched chain ketoacid dehydro-
genase appeared also elevated in both male and female
Aqp9/ mice (Fig. 2C). Branched chain ketoacid dehy-
drogenase was not part of the Metscape amino acid–TCA
cycle–butanoate network. However, the enzyme is known
to efficiently catalyze the conversion of 2-oxobutanoate to
propanoyl-CoA (Jones and Yeaman 1986), which is an
important substrate in this network.
Discussion
Aqp9 gene deletion effectively reduces postprandial blood
glucose in a mouse model of type 2 diabetes (Rojek et al.
2007). In that study, leptin receptor–deficient db/db mice
of mixed genetic background, C57BL/6 9 C57BLKS, were
used. Importantly, these genetic backgrounds differ signifi-
cantly in their diabetic phenotype and disease progression:
C57BLKS db/db mice develop severe diabetes characterized
by hyperphagia, obesity, hyperglycemia, transient hyperin-
sulemia, and progressive pancreatic islet failure. In contrast,
C57BL/6 db/db mice are hyperphagic, but display a more
moderate phenotype that is explained by marked pancreatic
hypertrophy partially compensating for insulin resistance
(Hummel et al. 1972). Thus, C57BLKS db/db mice may be
viewed as a model of late stage human type 2 diabetes,
while the phenotype of C57BL/6 mice resembles an early
diabetic or prediabetic, obese, insulin-resistant pathology.
Given the fundamental differences in these two mouse
models, we decided to investigate the impact of Aqp9
gene deletion in C57BL/6 db/db mice. We observed a
moderate increase in blood glucose in these mice, con-
trasting the marked decrease in postprandial blood glu-
cose observed in C57BLKS9C57BL/6 db/db mice (Rojek
et al. 2007). A probable explanation for this unanticipated
observation is divergent insulin control over hepatic glu-
cose production between these mouse strains. The role of
insulin in the regulation of hepatic glucose output is well
established and affects both gluconeogenesis and
glycogenolysis (Raddatz and Ramadori 2007). In healthy,
postprandial animals hepatic glucose output is moderate.
Similar balance, including moderate glycerol gluconeogen-
esis may be achieved in compensatory hyperinsulemic
C57BL/6 db/db mice. On the other hand, hepatic glycerol
gluconeogenesis may be constitutively elevated in
C57BLKS mice. Interestingly, glucagon secretion is
enhanced in pancreatic islet cells isolated from C57BLKS
mice (Leiter et al. 1979). Constitutively elevated glucagon
would likely result in elevated gluconeogenesis.
In the mixed genetic background hepatic glucose out-
put is affected by random distribution of modifier genes
A
B
C
Figure 2. Analysis of GC-MS and microarray gene expression
profiling of C57BL/6 db/db Aqp9wt and Aqp9/ mice. (A) OPLS-
DA facilitates plasma sample classification by genotype, indicating
systematic differences in plasma metabolite profile between
Aqp9/ and Aqp9wt mice. Black = Aqp9/; gray = Aqp9wt;
circle = male; triangle = female. (B) Relative abundance of plasma
metabolites of OPLS-DA VIP score >1 in Aqp9wt (WT) and Aqp9/
(KO) mice. VIP scores are sorted from left-highest to right-
lowest. Metabolites with FDR < 0.1 in univariate statistics (*).
(C) Relative gene expression of Bckdhb and Nt5e in Aqp9wt (WT)
and Aqp9/ (KO) mice, t-test: Bckdhb P = 0.0355 (male),
P = 0.0036 (female); Nt5e P = 0.0599 (male), P = 0.0113 (female),
FDR > 0.1.
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in the genetic background. We can currently not rule out
the possibility of genetic linkage between Aqp9 and a
putative modifier gene present in C57BLKS mice that
may have accounted for reduced blood glucose levels in
Aqp9/ mice on the mixed genetic background.
We did not find any signs of changes in hepatic steato-
sis, contradicting a recent finding of reduced NAFLD in
lentivirus-associated Aqp9 RNA interference treated high-
fat diet-fed Sprague Dawley rats (Cai et al. 2013). How-
ever, differences in the model and species used may
account for this discrepancy. Comprehensive analyses of
liver gene expression and liver as well as plasma metabo-
lite levels did not reveal any strong effects of Aqp9 gene
deletion on all measured parameters. However, elevated
plasma glycerol levels indicated that AQP9 function is
reduced in these mice. Moderately elevated plasma glu-
cose concentration in Aqp9/ mice, established with two
independent methods, may thus reflect a compensatory
shift in glucose metabolism presumably due to altered
hormonal control. Average plasma insulin was indeed
lower in the analyzed Aqp9/ mice even though data
varied considerably between individual animals. This
observation suggests reduced compensatory pancreatic
hypertrophy in AQP9/ mice, possibly as a result of
abolished hepatic glycerol gluconeogenesis (Jelen et al.
2011). Further putative compensatory adaptations were
detected, including changes in adenine, uracil, malate,
fumarate, and glycerates. Hypothetical pathway connec-
tions for these substances, including placement of two
differentially expressed genes within the microarray data
set, Nt5e as well as Bckdhb based on Metscape analysis are
depicted in Figure 3. Based on known activity on 2-
oxobutanoate (Jones and Yeaman 1986), elevated Bckdhb
expression may explain depletion of several observed
metabolites from Aqp9/ mouse plasma.
Nt5e is a plasma membrane protein that catalyzes the
conversion of extracellular nucleotides to membrane-
permeable nucleosides. Interestingly functional muta-
tions in Nt5e are the cause of an inherited form of
severe atherosclerosis: arterial calcification due to defi-
ciency of CD73 (St Hilaire et al. 2011). On the other
hand, high Aqp9 expression has been associated with
atherosclerosis in mice and humans (Inouye et al.
2012). While the reason for elevated plasma adenine
and Nt5e expression in Aqp9/ mice remains unclear,
this observation provides an explanation for the correla-
tion between Aqp9 expression and the development of
atherosclerosis.
Conclusions
We find that Aqp9 gene deletion results in opposite phe-
notypic changes regarding glucose metabolism in a mouse
model of early stage diabetes, compared to a previous
study utilizing a mouse model of late stage diabetes (Ro-
jek et al. 2007). While observations in mice are not read-
ily applicable to treatment of human diabetes, we believe
it is important to consider these effects of genetic back-
ground in future research of glycerol gluconeogenesis in
type 2 diabetes.
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